Abstract:Aim To investigate the role and regulatory mechanism of CREB regulated transcription coactivator 2 (CRTC2) in cardiomyocyte hypertrophy. Methods A pathological cardiomyocyte hypertrophy model was established in C57BL/6 mice by intraperitoneal injection of isoproterenol (ISO), the expression of CRTC2 in cardiac tissue was detected by Western blot. The CRTC2 knockout mice model was constructed, the cardiac function of mice was detected by small animal echocardiography, the collagen fiber content in mice cardiac tissue was detected by Masson staining, the cardiomyocyte hypertrophy related proteins:skeletal muscle α1-actin (ACTA1) and brain natriuretic peptide (BNP), as well as ferroptosis related proteins:acyl-CoA synthetase long chain family member 4 (ACSL4), solute carrier family 7 member 11 (SLC7A11) and glutathione peroxidase 4 (GPX4) in mice cardiac tissue were detected by Western blot, the iron ion content in mice cardiac tissue was detected by iron ion kit, to evaluate the correlation between CRTC2 and cardiomyocyte hypertrophy and ferroptosis. H9c2 cells were induced by ISO to construct an in vitro model of cardiomyocyte hypertrophy, the protein expressions of CRTC2, ACTA1, BNP, ACSL4, SLC7A11 and GPX4 were detected after intervention with ferroptosis inhibitor ferrostatin-1 (Fer-1). H9c2 cells with CRTC2 overexpression induced by ISO were used to construct an in vitro model of cardiomyocyte hypertrophy, the related indicators of cardiomyocyte hypertrophy and ferroptosis were detected to explore the mechanism of CRTC2 in cardiomyocyte hypertrophy. Results Compared with the control group, the expression of CRTC2 protein in the cardiac tissue of ISO induced cardiomyocyte hypertrophy mice was increased (P<0.05). Compared with wild-type mice, CRTC2-/- mice showed worsened cardiac function, manifested as increased left ventricular end-diastolic diameter (LVEDD), left ventricular end-systolic diameter (LVESD), left ventricular posterior wall thickness (LVPWT), heart weight/tibia length (HW/TL) and heart weight/body weight (HW/BW), decreased short axis shortening (FS) and ejection fraction (EF), increased collagen fiber content in cardiac tissue, upregulated expression of cardiomyocyte hypertrophy-related proteins ACTA1 and BNP, increased mRNA and protein expression of ferroptosis-related protein ACSL4, decreased mRNA and protein expression of SLC7A11 and GPX4, and elevated iron ion content in cardiac tissue (P<0.05 or P<0.01). In vitro experiments showed that compared with ISO group, the ISO+Fer-1 group had no significant change in CRTC2 protein expression (P>0.05), the expression of ACTA1 and BNP protein decreased, the surface area of cardiomyocyte reduced, the expression of ACSL4 protein decreased, and the expression of SLC7A11 and GPX4 proteins increased (P<0.05 or P<0.01). Compared with the ISO group, the LV-CRTC2+ISO group showed a decrease in surface area of cardiomyocytes (P<0.01), a decrease in ACTA1, BNP and ACSL4 protein expression, an increase in SLC7A11 and GPX4 protein expression, and a decrease in ROS and iron ion content (P<0.05 or P<0.01). Conclusion CRTC2 alleviates cardiomyocyte hypertrophy and protect cardiac function by suppressing ferroptosis in cardiomyocytes.